80 related articles for article (PubMed ID: 25533883)
1. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
Alford SH; Rattan R; Buekers TE; Munkarah AR
Cancer; 2015 Feb; 121(3):441-7. PubMed ID: 25533883
[TBL] [Abstract][Full Text] [Related]
2. Metformin and the risk of endometrial cancer: a population-based cohort study.
Ko EM; Stürmer T; Hong JL; Castillo WC; Bae-Jump V; Funk MJ
Gynecol Oncol; 2015 Feb; 136(2):341-7. PubMed ID: 25499603
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonate use and risk of postmenopausal endometrial cancer.
Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT
J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
5. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
6. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.
Rennert G; Rennert HS; Pinchev M; Lavie O
Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062
[TBL] [Abstract][Full Text] [Related]
7. Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones.
Stevens VL; Jacobs EJ; Patel AV; Sun J; Gapstur SM; McCullough ML
Cancer Causes Control; 2014 Mar; 25(3):321-8. PubMed ID: 24381074
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
[TBL] [Abstract][Full Text] [Related]
10. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.
Segev Y; Iqbal J; Lubinski J; Gronwald J; Lynch HT; Moller P; Ghadirian P; Rosen B; Tung N; Kim-Sing C; Foulkes WD; Neuhausen SL; Senter L; Singer CF; Karlan B; Ping S; Narod SA;
Gynecol Oncol; 2013 Jul; 130(1):127-31. PubMed ID: 23562522
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
12. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.
Pinsky PF; Miller A; Kramer BS; Church T; Reding D; Prorok P; Gelmann E; Schoen RE; Buys S; Hayes RB; Berg CD
Am J Epidemiol; 2007 Apr; 165(8):874-81. PubMed ID: 17244633
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
[TBL] [Abstract][Full Text] [Related]
15. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis.
Myung SK; Ju W; Choi HJ; Kim SC;
BJOG; 2009 Dec; 116(13):1697-705. PubMed ID: 19775307
[TBL] [Abstract][Full Text] [Related]
18. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
Beiki O; Allebeck P; Nordqvist T; Moradi T
Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
